Cargando…
Cyclosporine and Extracorporeal Photopheresis are Equipotent in Treating Severe Atopic Dermatitis: A Randomized Cross-Over Study Comparing Two Efficient Treatment Modalities
Background: Severe atopic dermatitis (AD) is a recurrent and debilitating disease often requiring systemic immunosuppressive treatment. The efficacy of cyclosporine A (CsA) is well proven but potential side effects are concerning. Several reports point at extracorporeal photopheresis (ECP) as an alt...
Autores principales: | Koppelhus, Uffe, Poulsen, Johan, Grunnet, Niels, Deleuran, Mette Søndergaard, Obitz, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292191/ https://www.ncbi.nlm.nih.gov/pubmed/25593907 http://dx.doi.org/10.3389/fmed.2014.00033 |
Ejemplares similares
-
Extracorporeal Photopheresis—An Overview
por: Cho, Ara, et al.
Publicado: (2018) -
Guidelines on the use of extracorporeal photopheresis
por: Knobler, R, et al.
Publicado: (2014) -
Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results
por: Nygaard, Uffe, et al.
Publicado: (2016) -
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
por: Bojanic, Ines, et al.
Publicado: (2023) -
Extracorporeal photopheresis: Review of technical aspects
por: Arora, Satyam, et al.
Publicado: (2017)